Burlingame, CA, Oct. 03, 2025 (GLOBE NEWSWIRE) — The Cannabidiol Market is estimated to be valued at USD 9.46 Bn in 2025 and is expected to reach USD 27.57 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 16.5% from 2025 to 2032. The cannabidiol market is projected to experience steady growth during the forecast period, driven by rising R&D investments and the expanding legalization of medical cannabis across multiple regions. Increasing health awareness and broader acceptance of cannabidiol’s therapeutic benefits in managing diverse health conditions are further expected to boost global investment and market expansion.

Request Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/4613

Global Cannabidiol Market Key Takeaways

Hemp remains the most widely used source for cannabidiol production, with the target segment expected to account for 58.6% of the global cannabidiol market share in 2025.

Cannabidiol oil is projected to remain the top-selling product during the forecast period.

Cannabidiol consumption is expected to remain high in medical applications throughout the projection period.

North America is set to account for over two-fifths of the global cannabidiol industry share in 2025, making it the market leader.

Asia Pacific is poised to emerge as the most lucrative pocket for cannabidiol manufacturers over the forecast period.

Increasing Acceptance and Legalization Fueling Market Growth

Coherent Market Insights’ new cannabidiol market analysis outlines prominent factors driving industry growth. One such key growth factor is the increasing acceptance and legalization of cannabidiol (CBD).

Many nations are easing laws around hemp-derived cannabidiol. As of September 2025, nearly 50 countries have fully or partially legalized cannabis for medical and/or recreational use. For instance,

In December 2024, Japan changed its laws to allow the use of cannabis-derived drugs containing CBD.

In August 2024, Ukraine legalized medical cannabis, including CBD products, for patients with prescriptions.

This wave of legalization is increasing consumer access and demand for CBD products. It is creating a more stable market as well as encouraging businesses to enter the industry.

Immediate Delivery Available | Buy This Premium Research Report: https://www.coherentmarketinsights.com/insight/buy-now/4613

Government Restrictions and Limited Scientific Evidence Limiting Market Growth

The global cannabidiol market outlook appears promising, owing to expanding medical applications. However, government restrictions on CBD usage and limited scientific evidence might limit market growth to some extent during the forthcoming period.

Many countries are putting limits on cannabidiol (CBD) to stop misuse. For example, in June 2025, Italy introduced strict rules on CBD products. This may slow down cannabidiol market growth during the assessment period.

In addition, many health claims about CBD are not fully supported by strong clinical evidence. This makes it difficult for regulators to approve it for medical use. Limited scientific backing may also reduce consumer confidence, thereby dampening overall cannabidiol market demand.

Escalating Demand for Natural Wellness Products Opening Growth Avenues

There is a growing consumer preference for natural and plant-based wellness products in the contemporary world. …

Full story available on Benzinga.com